glp-1 mood improvement Receptor Agonists in Disorders: A Psychiatric Perspective GLP-1 trials show mood improvement – GLP-1 receptor agonists improve mood

Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases. Current Psychiatry Research and Reviews Formerly: Current Psychiatry Reviews, vol

p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells

Status Injectable NAD+ is not FDA-approved as a therapeutic

This can slow metabolism over time if not managed carefully

Participants were randomised (4:1) to receive once-weekly subcutaneous injections of HRS9531 or placebo across four dose cohorts (1.0mg, 3.0mg, 4.5mg and 6.0mg) for 24 weeks.